ESSA Pharma Stock Buy Hold or Sell Recommendation

Stocks . USA . 
Stock . ESSA Pharma
EPIX Stock  USD 2.97  0.08  2.62%   
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding ESSA Pharma is 'Cautious Hold'. Macroaxis provides ESSA Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EPIX positions. The advice algorithm takes into account all of ESSA Pharma's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from ESSA Pharma's buy-and-hold perspective. Check out ESSA Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ESSA Pharma Stock please use our How to Invest in ESSA Pharma guide.We conduct extensive research on individual companies such as ESSA Pharma and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards ESSA Pharma.

Execute ESSA Pharma Buy or Sell Advice

The ESSA Pharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ESSA Pharma. Macroaxis does not own or have any residual interests in ESSA Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ESSA Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell ESSA PharmaBuy ESSA Pharma
Cautious Hold

Volatility

Slightly risky
Details

Hype Condition

Under hyped
Details

Current Valuation

Undervalued
Details

Odds of Distress

Close to Average
Details

Economic Sensitivity

Responds to the market
Details

Analyst Consensus

Strong Buy
Details

Financial Strenth (F Score)

Frail
Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Unlikely Manipulator
Details
For the selected time horizon ESSA Pharma has a Mean Deviation of 3.22, Semi Deviation of 3.51, Standard Deviation of 3.86, Variance of 14.92, Downside Variance of 14.15 and Semi Variance of 12.34
We provide trade advice to complement the prevailing expert consensus on ESSA Pharma. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available now. To make sure ESSA Pharma is not overpriced, please confirm all ESSA Pharma fundamentals, including its total debt, as well as the relationship between the earnings per share and retained earnings . Please also check ESSA Pharma price to earning to verify your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself next year.

ESSA Pharma Trading Alerts and Improvement Suggestions

ESSA Pharma has very high historical volatility over the last 90 days
Net Loss for the year was (35.1 M) with profit before overhead, payroll, taxes, and interest of 0.
ESSA Pharma currently holds about 174.6 M in cash with (28.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
ESSA Pharma has a frail financial position based on the latest SEC disclosures
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

ESSA Pharma Returns Distribution Density

The distribution of ESSA Pharma's historical returns is an attempt to chart the uncertainty of ESSA Pharma's future price movements. The chart of the probability distribution of ESSA Pharma stock daily returns describes the distribution of returns around its average expected value. We use ESSA Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ESSA Pharma returns is essential to provide solid investment advice for ESSA Pharma.
Mean Return0.14Value At Risk-5.5
Potential Upside6.52Standard Deviation3.86
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ESSA Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Backtest ESSA Pharma

ESSA Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ESSA Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ESSA Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ESSA Pharma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite		0.20
β
Beta against NYSE Composite1.30
σ
Overall volatility		3.79
Ir
Information ratio 0.0469

ESSA Pharma Volatility Alert

ESSA Pharma shows above-average downside volatility for the selected time horizon. We advise investors to inspect ESSA Pharma further and ensure that all market timing and asset allocation strategies are consistent with the estimation of ESSA Pharma future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ESSA Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ESSA Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

ESSA Pharma Fundamentals Vs Peers

Comparing ESSA Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ESSA Pharma's direct or indirect competition across all of the common fundamentals between ESSA Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as ESSA Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ESSA Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare ESSA Pharma to competition
FundamentalsESSA PharmaPeer Average
Return On Equity(0.19) %(0.31) %
Return On Asset(0.13) %(0.14) %
Current Valuation(35.25 M)16.62 B
Shares Outstanding44.09 M571.82 M
Shares Owned by Insiders5.83 %10.09 %
Shares Owned by Institutions76.48 %39.21 %
Number of Shares Shorted236.8 K4.71 M
Price to Earning(1.12) X28.72 X
Price to Book0.79 X9.51 X
EBITDA(35.08 M)3.9 B
Net Income(35.1 M)570.98 M
Cash and Equivalents174.6 M2.7 B
Cash per Share3.96 X5.01 X
Total Debt242.14 K5.32 B
Debt to Equity0.001 %48.70 %
Current Ratio43.43 X2.16 X
Book Value Per Share3.67 X1.93 K
Cash Flow from Operations(28.7 M)971.22 M
Short Ratio1.12 X4.00 X
Earnings Per Share(0.74) X3.12 X
Target Price21.6
Number of Employees5018.84 K
Beta2.11-0.15
Market Capitalization131.4 M19.03 B
Total Asset169.51 M29.47 B
Retained Earnings(50.63 M)9.33 B
Working Capital6.39 M1.48 B
Current Asset10.02 M9.34 B
Current Liabilities3.63 M7.9 B
Net Asset169.51 M
   Sale by Franklin Berger of 43617 shares of ESSA Pharma [view details]

ESSA Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ESSA Pharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution3688.78
Daily Balance Of Power(0.42)
Rate Of Daily Change0.97
Day Median Price3.05
Day Typical Price3.02
Market Facilitation Index0.0
Price Action Indicator(0.11)

About ESSA Pharma Buy or Sell Advice

When is the right time to buy or sell ESSA Pharma? Buying financial instruments such as ESSA Pharma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2020 2021 2022 2023 (projected)
Current Assets197.6 M169.06 M194.42 M209.77 M
Total Assets198.17 M169.51 M194.93 M210.32 M

Use Investing Ideas to Build Portfolios

In addition to having ESSA Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Crypto And Gold Thematic Idea Now

Crypto And Gold
Crypto And Gold Theme
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 55 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
View All  Next Launch
Check out ESSA Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ESSA Pharma Stock please use our How to Invest in ESSA Pharma guide. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for analysis

When running ESSA Pharma price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA Pharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74) 
Return On Assets
(0.13) 
Return On Equity
(0.19) 
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA Pharma that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine ESSA Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY